# DESCRIPTION

## FIELD OF THE INVENTION

- relate to ultrastable gold nanoparticles

## BACKGROUND OF THE INVENTION

- introduce gold nanoparticles
- describe properties of gold nanoparticles
- discuss challenges of AuNPs stability
- summarize previous synthesis methods
- describe limitations of previous methods
- introduce biocompatible ligands
- discuss importance of ultrastable AuNPs
- motivate need for new synthesis conditions
- propose new synthesis conditions

## SUMMARY OF THE INVENTION

- introduce ultrastable AuNPs with biocompatible ligand
- describe use of AuNPs as carrier for medicament
- summarize composition and formulation
- outline method of treatment

## DETAILED DESCRIPTION OF PARTICULAR EMBODIMENTS

- describe novel synthesis conditions

### Method of Synthesis

- describe steps of synthesis method
- provide example of synthesis method
- describe alternative synthesis method
- provide another example of synthesis method
- describe further alternative synthesis method
- provide yet another example of synthesis method

### Ultrastable NPs

- describe properties of ultrastable AuNPs
- outline stability of AuNPs under cold and heat treatment
- describe absorption spectrum of AuNPs

### Biocompatible Ligand

- describe biocompatible ligand
- provide examples of biocompatible ligands

### Use as Carrier

- describe use of AuNPs as carrier for medicament

### Composition, Formulation

- describe composition and formulation

### Method of Treatment

- describe method of treatment

### Therapeutic Indications

- describe therapeutic indications

### Mode of Administration

- describe mode of administration

### Dosage

- describe dosage of travoprost
- outline administration intervals

## EXAMPLES

### Example 1

- describe chemical synthesis of AuNPs
- detail physicochemical characterizations
- determine weight of AuNPs
- measure absorbance by UV-visible spectroscopy
- assess stability of NPs
- calculate diameter of gold core
- determine number of gold atoms
- describe mucoadhesion measurements
- correct for inner filter effect
- present results of AuNPs synthesis
- show UV-visible spectra of AuNPs
- display TEM images of AuNPs
- determine molecular weight of AuNPs
- measure Zeta potential of AuNPs
- calculate hydrodynamic diameter of AuNPs

### Example 2

- describe encapsulation protocol
- detail conditions of encapsulation
- encapsulate travoprost
- encapsulate timolol
- determine encapsulation efficiency
- illustrate encapsulation kinetics
- show calibration curves of travoprost and timolol

### Example 3

- describe in vivo glaucoma model
- detail material and methods
- assess drug vector toxicity
- encapsulate travoprost
- characterize encapsulation
- validate model of hypertensive glaucoma
- show improvement of travoprost effects by AuNPs
- conclude on sustained effect of AuNPs on intraocular pressure

